University Of Melbourne

Parkville, VIC Doing business as The University Of Melbourne

UEI
P8JJC89CWNK5
CAGE
Z0BA1
Primary NAICS
611310 Colleges, Universities, and Professional Schools
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
International Organization
SAM.gov registration date
Physical address
Raymond Priestley Building, Parkville VIC 3010, Australia
Website
unimelb.edu.au
Founded
1853
Employees
5K-10K
Estimated annual revenue
$1B-$10B
Industry
  1. Consumer Discretionary
  2. Diversified Consumer Services
  3. Education Services
  4. Education
SIC code
82 Educational Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
University Of Georgia Research Foundation, Inc. UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE Center for Influenza Disease and Emergence Research… 75N93021C00018 $179,154
University Of Georgia Research Foundation, Inc. UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE Center for Influenza Disease and Emergence Research… 75N93021C00018 $706,514
University Of Georgia Research Foundation, Inc. UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) NIAID Centers of Excellence for Influenza… 75N93021C00018 $610,379
Emory University EMORY CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR). Emory CEIRR 75N93021C00017 $124,285
Emory University EMORY CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR). Emory CEIRR 75N93021C00017 $317,923

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Not on record Exploring Next Generation Modeling Solutions to Enhance Preparedness for FMD Outbreaks in USA 5830224019 $50,000
University Of Missouri System Koskinen addresses Objective III: grounding the proposed research in social network applications and applying the proposed methods to covert networks. W911NF2110335 -$27,580
Childrens Hospital Medical Center Intramuscular vs Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial (GOALIE) R33HL166441 $62,634
University Of Washington Host Pathogen Variation & TB Pathogenesis. U19AI162583 $158,490
The Trustees Of Columbia University In The City Of New York Title: Breast Cancer Family Registry Prime: Columbia University Contact PI: Mary Beth Terry, PhD Project Period: 05/01/2025 – 04/30/2028 Sub-contractor:… U01CA164920 $116,168

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

The University Of Melbourne, a nonprofit research institution headquartered in Parkville, Victoria, Australia, operates as a federal grant recipient and subcontractor across biomedical research, basic science, and defense technology development, with the majority of its recent award activity (73%) as a prime grant recipient rather than as a contractor or prime on service contracts.

The University's federal footprint centers on biomedical and life-science research. Recent prime grant awards include a $3.242 million Defense Advanced Research Projects Agency (DARPA) cooperative agreement (CFDA 12.910) for the COASTERCHASE program running through December 2027; a $4.319 million Defense Health Agency (DHA) project grant (CFDA 12.420) on "Targeting Senescent Cells to Improve Outcomes for Breast Cancer Patients" through August 2028; a $1.121 million DHA award for novel biological therapies targeting HER2 for advanced breast cancer treatment through March 2029; a $819 thousand National Institute of Allergy and Infectious Diseases (NIAID) project grant (CFDA 93.855) for CRISPR-Cas13-based HIV therapeutic approaches through August 2030; and a $562 thousand National Institute of Child Health and Human Development (NICHD) award (CFDA 93.865) for machine learning tools assessing maternal medication safety during lactation, running through March 2031. Additional DHA awards fund research on Parkinson's disease constipation ($968 thousand through April 2028), myalgic encephalomyelitis/chronic fatigue syndrome ($389 thousand through January 2027), minimally-invasive brain pressure measurement post-traumatic brain injury ($721 thousand through October 2028), and melanoma progression ($733 thousand through August 2026). The University also holds cooperative agreements with NIAID on influenza vaccine effectiveness (CFDA 93.855) and with the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) on ketone monitoring thresholds in Type 1 Diabetes management.

Customer concentration is driven by defense and health research agencies. The top five funding customers account for 43% of recent awards by count: the Defense Health Agency (24 awards), NIAID (23 awards), the National Institutes of Health (13 awards), the National Institute on Aging (13 awards), and the Department of the Navy (13 awards). Dollar concentration differs slightly—the Army Materiel Command's Research Development and Engineering Command anchors the largest single dollar block ($1.1 million across 5 awards), while NIH institutes collectively represent the deepest engagement. The University serves 40 distinct federal customer agencies.

The University operates predominantly as a grant recipient and sub-recipient, not as a federal contractor. Across SCI-reported service contracts above the $150,000 threshold, the University appears in 8 records, all as a named subcontractor (zero as prime), with FTE delivery declining from 2.7 FTEs in FY2022 to 0.4 FTEs in FY2025. Sub-recipient grant relationships dominate the subcontract footprint. Named prime-grantee relationships include the University of Georgia Research Foundation (for NIAID Centers of Excellence for Influenza Research and Response sub-awards in 2024, 2025, and 2026), Emory University (NIAID CEIRR in 2024), Boston University (CARB-X Global Antibacterial Accelerator OTA in 2023), and multiple NIH-funded university consortia including Duke University, the University of Pennsylvania, Stanford University, New York University, and the University of Southern California. The University of Melbourne serves as a data analysis, laboratory, and field-coordination sub-recipient on multi-site clinical trials and research programs, such as the Breast Cancer Family Registry (Columbia University prime), DIAN-TU trials (Washington University prime), ENIGMA depression neuroimaging studies (Duke and USC primes), and HIV latency research (University of California San Francisco prime).

Activity has fluctuated, with 27 awards in 2024 followed by a slowdown to 12 in 2025 and 10 so far in 2026. Thirteen awards reach ultimate completion within the next twenty-four months, representing a recompete window for defense and NIH biomedical research funding. Work is performed in Australia and at subordinate sites; the NICHD lactation research, for example, lists place of performance in Hanover, New Hampshire while the University is based in Australia, reflecting distributed research delivery on federally funded projects.

Quick answers

Is University Of Melbourne registered in SAM.gov?

Yes. University Of Melbourne's SAM.gov registration is active through January 12, 2027.

What is University Of Melbourne's most recent federal award?

University Of Melbourne's most recent federal grant award is DE-risking therapeutic use in the context of lactation by coupling perturbation studies and machine learning… (R01HD121632), from National Institute of Child Health and Human Development (NIH), on June 19, 2026.

On GovTribe

See University Of Melbourne's full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors